19
Mar
2020
COVID-19 Response – the Roadmap Not Followed
Public health is not sexy. Vaccines haven’t been a good business investment. But what has become abundantly clear is that infectious disease preparedness can have a greater impact on morbidity and mortality than all the sexy innovative therapies combined. We are looking down the barrel of a gun. We are about to get blown away by a pandemic as the...Read More 
Share:
19
Mar
2020
Singapore: What We Can Learn From a High-risk Country’s Response to COVID19
I was born in Malaysia, but left my family for the promised land of Singapore at the age of 12 under a scholarship program known as the ASEAN program. I lived more than half my life in that country, and have long since become a Singaporean. I currently manage a major Singaporean life sciences VC fund from a San Francisco...Read More
Share:
19
Mar
2020
The Biopharmaceutical Counterattack
The latest contagious and deadly global virus, COVID-19, is invisibly sprinting across the world and across America. As the crisis engulfs our nation, it has exposed failures to heed the warnings of experts that would have allowed us to arm ourselves for what we have long known to be this inevitable threat. Worse yet, critical capacities that would have allowed...Read More
Share: